Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 236012
                    [Title] => Landmark trial shows benefits of ‘valsartan’
                    [Summary] => Internationally respected medical authorities reported at the American Heart Association meeting held recently in Orlando, Florida that valsartan, a drug for high blood pressure belonging to the angiotensin II receptor blocker (ARB) family, is as effective as the ACE-inhibitor captopril in reducing the risk of death and other non-fatal cardiovascular events (CV) among high-risk patients, as results of the VALIANT study show.


                    [DatePublished] => 2004-01-22 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

NOVARTIS MEDICAL CENTER

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 236012
                    [Title] => Landmark trial shows benefits of ‘valsartan’
                    [Summary] => Internationally respected medical authorities reported at the American Heart Association meeting held recently in Orlando, Florida that valsartan, a drug for high blood pressure belonging to the angiotensin II receptor blocker (ARB) family, is as effective as the ACE-inhibitor captopril in reducing the risk of death and other non-fatal cardiovascular events (CV) among high-risk patients, as results of the VALIANT study show.


                    [DatePublished] => 2004-01-22 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Landmark trial shows benefits of ‘valsartan’

January 22, 2004 - 12:00am

Internationally respected medical authorities reported at the American Heart Association meeting held recently in Orlando, Florida that valsartan, a drug for high blood pressure belonging to the angiotensin II receptor...

Science and Environment